3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
28
Colonic Neoplasms
12
Rectal Neoplasms
5
Recurrence
4
Neoplasms
4
Esophageal Neoplasms
4
Barrett Esophagus
4
Stomach Neoplasms
3
Gastrointestinal Neoplasms
3
Precancerous Conditions
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colonic Diseases
2
Cardiovascular Diseases
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Adenoma
2
Rectal Diseases
1
Prostatic Neoplasms
1
Polyps
1
Pathologic Processes
1
Lynch syndrome I (site-specific colonic cancer)
1
Inflammation
1
Interventions
ficlatuzumab
1
Sunitinib
1
Electrochemotherapy
1
Bleomycin
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Processes
×
Aspirin
×
Gastrointestinal
×
Clear all
NCT03464305
2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3
Active not recruiting
148 enrolled